Glucagon-like peptide 2-(3-33) removes the first two and last residues, focusing analysis on the core GLP-2 region. The fragment is used to examine cleavage patterns, folding transitions, and receptor-binding determinants. Researchers apply it in structure-activity mapping of GLP-2 segments. Its defined truncation supports biophysical and mechanistic assessments.
CAT No: G16035
CAS No:275801-62-2
Synonyms/Alias:glucagon-like peptide 2-(3-33);275801-62-2;GLP-2 (3-33);GLP-2(3-33);GLXC-26361;DA-53589;
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.